What is the appropriate dose of ferrous sulfate elixir for an adult?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 26, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ferrous Sulfate Elixir Dosing for Adults

For adults with iron deficiency anemia, start with ferrous sulfate elixir providing 50-100 mg of elemental iron once daily, taken on an empty stomach in the morning. 1

Recommended Dosing Regimen

The British Society of Gastroenterology 2021 guidelines provide the most comprehensive and recent evidence-based approach 1:

  • Initial dose: One dose daily providing 50-100 mg elemental iron
  • Timing: Morning, fasting state (empty stomach)
  • With: Approximately 100 mg vitamin C or citrus juice to enhance absorption 2
  • Avoid: Taking with food, milk, tea, coffee, calcium supplements, antacids, or acid-suppressing medications 2

Ferrous Sulfate Elixir Formulations

According to the available formulations 1:

  • Ferrous sulfate drops/liquid: 125 mg/mL (provides 25 mg elemental iron per mL)
  • To achieve 50-100 mg elemental iron: 2-4 mL daily

The FDA-labeled tablet formulation indicates 324 mg ferrous sulfate = 65 mg elemental iron 3, which translates proportionally for liquid preparations.

If Initial Regimen Not Tolerated

Switch to alternate-day dosing rather than changing iron salts 1:

  • Same dose (50-100 mg elemental iron) every other day
  • This approach increases fractional iron absorption and significantly reduces gastrointestinal side effects 1
  • Evidence shows alternate-day dosing achieves similar hemoglobin increases with better tolerance 1

Monitoring and Duration

  • Check hemoglobin at 2 weeks: Expect ≥10 g/L rise if treatment is working 1
  • Continue monitoring every 4 weeks until hemoglobin normalizes 1
  • After hemoglobin normalizes: Continue treatment for 2-3 months to replenish iron stores 1

Critical Pitfalls to Avoid

  1. Do NOT prescribe twice-daily dosing initially: The 2024 AGA guidelines note that 60 mg elemental iron stimulates hepcidin, reducing subsequent iron absorption by 35-45%, making once-daily dosing as effective as twice-daily 1

  2. Do NOT switch between different iron salts for intolerance: Evidence does not support this common practice 1. Instead, use alternate-day dosing or consider parenteral iron

  3. Do NOT take with food to reduce side effects: While this is commonly done, it markedly reduces absorption 2. If GI symptoms occur, switch to alternate-day dosing instead

  4. Do NOT have patient lie down within 30-60 minutes after taking liquid iron to reduce risk of esophageal irritation 2

When to Consider Parenteral Iron

Switch to IV iron if 4, 1:

  • No hemoglobin rise ≥10 g/L after 2 weeks of daily oral therapy
  • Intolerable side effects despite alternate-day dosing
  • Malabsorption conditions (inflammatory bowel disease, post-bariatric surgery)
  • Ongoing blood loss exceeding oral iron absorption capacity

The most recent evidence strongly supports starting conservatively with once-daily dosing rather than the traditional twice or three-times daily approach, as this optimizes the balance between efficacy and tolerability while accounting for hepcidin-mediated absorption limitations.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.